The clinical implications of TG2 expression in human breast cancer primary tumor tissue were examined with a tissue microarray from 443 patients with operable breast cancer treated at Seoul National University Hospital between February 2000 and December 2002. The gene discussed is TGM2; the disease is breast carcinoma.